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Background: : Aortic stiffness, an independent predictor of mortality and cardiovascular events, is common
among patients affected by non-ischemic dilated cardiomyopathy (NIDC) and heart failure (HF).
Methods: : A total of 55 patients with diagnosis of NIDC (aged 60±11 years,mean ejection fraction (EF) 35.2%±
7.7%) admitted consecutively to our department for mild to moderate HF (NYHA class II–III) underwent an
echocardiographic study and cardiopulmonary exercise test (CPX). We evaluated elastic properties of ascending
aorta, i.e. aortic stiffness and aortic distensibility (mmHg−1), derived from ascending aorta systolic and diastolic
diameter (mm/m2) measured 3 cm above the valvular plane through 2D-guided M-mode echocardiography.
Results: : Mean aortic stiffness was 15.63 ± 14.53 and aortic distensibility was 2.61 ± 2.39 mmHg−1. Collected
parameters at CPX were peak oxygen consumption (pVO2) (ml/kg/min), anaerobic threshold (AT) and the slope
of the relation between minute ventilation (VE) and carbon dioxide production (VCO2). Mean pVO2 was 15.4 ±
3.9 ml/kg/min, VE/VCO2 ratio at ATwas 36.1±6.1. Functional capacitymeasured throughpeakVO2was found to
be directly correlated with aortic distensibility (r = 0.47, p =−0.0002) and negatively correlated to aortic
stiffness index (r =−0.51, p =−0.0001). These results were the same at multivariate analysis, corrected by
age, hypertension, diabetes mellitus and ejection fraction (respectively r = 0.27, p = 0.008 and r =−1.75, p =
0.0002).
Conclusions: : HF patients due to NIDC elastic properties of ascending aorta, evaluated by echocardiography, are
correlated with a reduced functional capacity.
©2014 TheAuthors. PublishedbyElsevier Ireland Ltd. This is an open access article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The interaction between the heart and the peripheral vasculature is
one of the major determinants of cardiovascular performance. The
progression of myocardial systolic dysfunction in chronic heart failure
(CHF) is characterized by a reduction of left ventricular end-systolic
elastance (LVE) and increased arterial elastance (AE), or stiffness [1,2].
The relationship between AE and LVE represents the ventriculo-
arterial coupling that is an important determinant of net cardiac perfor-
mance and cardiac energetics [3]. Ventriculo-arterial coupling is known
to progressively increase in CHF due to a reduction in LVE and a raise in
AE [4,5]. The failing heart is so very linked to afterload conditions during
exercise. Many studies showed a progressive alteration of large-artery9 303996801.
liability and freedom from bias
nd Ltd. This is an open access article ufunction with the increasing severity of CHF [6]. Recent studies have
shown that increased aortic stiffness leads to an increased afterload
[7] and an impaired ventriculo-arterial coupling [8], thus reducing left
ventricular systolic function and exercise capacity in patients with CHF
[9,10].
The aim of our study was to demonstrate the possible relationship
between elastic properties of ascending aorta, evaluated noninvasively
by echocardiography, and clinical functional capacity evaluated by
cardiopulmonary test in patients with NIDC.
2. Methods
We evaluated 55 consecutive patients affected by mild to moder-
ate CHF due to NIDC with reduced left ventricular ejection fraction
(LVEF b 45%), admitted to Cardiology Department of Spedali Civili of
Brescia, Italy. 30 patients (55%) were in NYHA class II and 25 (45%) in
NYHA class III. They received standard therapy of CHF in accordance
with the European Society of Cardiology guidelines for the treatment ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Characteristics of the study population of mild- to moderate CHF (n = 55).
Age (years) 60 ± 11
Men/women 46 (83%)/9 (17%)
Body surface area (BSA) (m2) 1,96 ± 0,2
Systolic blood pressure (mm Hg) 119 ± 15.2
Diastolic blood pressure (mm Hg) 74,9 ± 8,2
Heart rate (bpm) 68,4 ± 10,8
Arterial hypertension 8 (15%)
Chronic obstructive pulmonary disease (COPD) 6 (10%)
Diabetes mellitus 9 (18%)
Smokers 3 (5%)
Dyslipidemia 17 (30%)
Data are presented as the mean value ± SD, or number (percentage) of patients.
Table 2
Main echocardiographic parameters of the study population (n = 55).
End diastolic diameter (EDD) (cm) 6.66 ± 0.79
End systolic diameter (ESD) (cm) 5.32 ± 0.95
End diastolic volume (EDV) (ml) 183.27 ± 82.58
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had a diagnosis of idiopathic cardiomyopathy.
The authors stated thatwritten informed consentwas obtained from
each patient and that the study protocol conforms to the ethical guide-
lines of the 1975 Declaration of Helsinki.
All the patients underwent a complete echocardiography-Doppler
examination (VIVID 7 echocardiograph General Electric Medical
Systems, Horten, Norway). Left ventricle end-diastolic and end-systolic
volumes, left ventricle end-diastolic and end-systolic diameters, ejection
fraction and also left ventricular wall thicknesses at end diastole and
end systole were measured in accordance with the guidelines [12]. The
Doppler method was used to calculate trans-mitral early and late ﬂow
velocities (E- and A-wave components) and deceleration time. The ratio
of early trans-mitral ﬂow velocity to early mitral annular velocity (E/E′)
was measured by tissue Doppler imaging [13]. LV diastolic dysfunction
was classiﬁed as proposed by the Group on Diastolic Heart Failure [14].
Systolic blood pressure in pulmonary artery (sPAP) was estimated using
Doppler echocardiography [15,16].
To evaluate aortic properties of ascending aorta we assessed aortic
size at four levels: Valsalva sinuses (VS), sino-tubular junction (STJ), as-
cending aorta (AA), and aortic arch (AAr) at the end of diastole and sys-
tole. So, aortic elastic indexes, i.e. distensibility (AoDis) and stiffness
(AoStif) were calculated from the echocardiographically derived thoracic
aortic diameters (indexed by body surface area—mm/m2) and assessed
on the basis of a two-dimensional guided M-mode recording of systolic
(AoS) and diastolic (AoD) aortic diameters, 3 cm above the aortic valve.
AoDwas obtained at the peak of the Rwave at the simultaneously record-
ed ECG, and AoS was measured at the maximal anterior motion of the
aorticwall; ﬁvemeasurementswere averaged for each diameter. The fol-
lowing indexes of aortic elasticity were calculated: AoDis = [2 × (AoS−
AoD) / AoD ∗ PP] (mm Hg−1); (AoStif) = ln(SBP/DBP) / [(AoS− AoD) /
AoD] (pure number) where SBP and DBP refer to brachial systolic and di-
astolic BP respectively, in mmHg and pulse pressure (PP) was calculated
as SBP− DBP [17].
All the patients underwent a cardiopulmonary exercise (CPX) test
(Marquette Hellige). It was used as a constant ramp protocol where
work rate was increased of 10 W/min. Gas exchange was monitored
during the exercise test with a spirometer and a computer metabolic
analysis (Medical Graphics). Collected parameters were peak oxygen
consumption (pVO2) expressed in ml/kg/min, anaerobic threshold
(AT) expressed in ml/kg/min, the slope of the relation between minute
ventilation (VE) and carbon dioxide production (VCO2). Peak VO2 was
measured as the mean value during the last 30 s of exercise.
All data are given asmean± standard deviation or number (percent-
age) of patients. Univariate and multivariate analyses were made to
assess a correlation between pVO2, age, LVEF, hypertension, diabetes
and aortic stiffness. Statistical signiﬁcance was established at a level of
p b 0.05.End systolic volume (ESV) (ml) 132.73 ± 94.38
End diastolic volume indexed (EDVi) (ml/m2) 74.36 ± 49.23
Left ventricular ejection fraction (LVEF) (%) 35.2 ± 7.7
Posterior wall thickness (PWT) (cm) 0.95 ± 0.14
Interventricular septum thickness (IVT) (cm) 1.05 ± 0.18
Left ventricular mass (LV mass) (g)
Valsalva sinuses (VS) (mm) 37.23 ± 6.37
Sino-tubular junction (STJ) (mm) 35.32 ± 2.56
Ascending aorta (AA) (mm) 42.93 ± 4.65
Aortic arch (Aar) (mm) 33.28 ± 2.96
Aorta in systole (AoS) (mm) 33.24 ± 5.03
Aorta in diastole (AoD) (mm) 34.95 ± 5.1
Aortic distensibility (mm Hg−1) 2.61 ± 2.39
Aortic stiffness index 15.63 ± 14.53
E/A ratio 0.75 ± 0.20
Deceleration time (DT) (msec) 244.6 ± 80.4
E/e′ ratio 14.7 ± 6.26
Pulmonary artery systolic pressure (mm Hg) 30.5 ± 5.5
Left atrium diameter (cm) 4.63 ± 0.9
Left atrium area (cm2) 25.01 ± 7.57
Data are presented as the mean value ± SD, or number (percentage) of patients.3. Results
Patients were 46 males (83%) and 9 females (17%). Mean age was
60 ± 11 years old. All patients were affected by CHF due to NIDC with
mean EF of 35.2% ± 7.7% and were treated with optimized medical
CHF-therapy according to current guidelines: ACE-I or ARB (96%), beta
blocker (96%), aldosterone receptor antagonist (64%) and diuretics
(70%).
All the other characteristics and all the echocardiographic parameters
are summarized respectively in Tables 1 and in 2.
Peak VO2 at CPXwas 15.4± 3.9 ml/kg/min, VE/VCO2 ratio at ATwas
36.1 ± 6.1; mean respiratory exchange ratio (RER) was 1.1 ± 0.14 thus
meaning that amaximummetabolic effort was performed. All the other
parameters evaluated during CPX were summarized in Table 3.
Mean AoDis was 2,61 ± 2.39 mm Hg−1 and mean aortic stiffness
15,63 ± 14,53.At univariate analysis only pVO2 was found to be directly correlated
with AoDis (r = 0.47, CI 0.25–0.66, p= 0.0002) and negatively correlat-
ed to AoStiff (r=−0.51, CI−0.68 to−0.20, p= 0.0001) [Figs. 1 and 2].
The correlations were also demonstrated at multivariate analysis,
corrected by hypertension, diabetes, age and ejection fraction (respec-
tively r = 0.27, p = 0.008 and r =−1.75, p = 0.0002). In Table 4 was
shown the predictors of peak volume oxygen consumption.
4. Discussion
This study demonstrates that aortic stiffness (measured non-
invasively using 2D guided M-mode echocardiography) is an indepen-
dent predictor of exercise capacity in patients with CHF and NIDC.
Our results are consistent with other reports that showed a correla-
tion between elastic properties of ascending aorta and functional capac-
ity in CHF patients using different echocardiographic methods [9,10].
The echocardiographic method used to evaluate aortic stiffness in CHF
patients is simple and easy to acquire and is not dependent on pulse
wave Doppler echocardiography.
An impaired aortic compliance is frequent among CHF patients
[18–20] and we showed that aortic stiffness is inversely related to
peak VO2, which is a major predictor of mortality among CHF patients
[21]. Our study cannot establish a causal relation between aortic stiff-
ness and decreased functional capacity. Actually, the elastic proximal
aorta is themain region that is affected by aging, hypertension, diabetes
or LV diastolic dysfunction. Therefore an increased aortic stiffness may
represent a marker of more advanced disease in CHF patients. Despite
that, several pathophysiological mechanisms suggest a possible causal
Table 3
CPX parameters of the study population (n = 55).
Peak VO2 (ml/kg/min) 15.4 ± 3.9
Peak VO2 (ml/min) 1284.13 ± 369.2
Max theoretical VO2 (ml/kg/min) 26.45 ± 5.02
Max theoretical VO2 percentage reached (%) 58.56 ± 14.26
Anaerobic Threshold (AT) (ml/kg/min) 10.55 ± 3.59
VE/VCO2 ratio at AT 36.1 ± 6.1
Respiratory Exchange Ratio (RER) 1.1 ± 0.14
Maximumworkload (Watt) 102.4 ± 30.59
Data are presented as the mean value ± SD, or number (percentage) of pts.
Fig. 2. Correlation between aortic stiffness and pVO2 (dashed lines represent±1 standard
deviation interval).
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population a relation between aortic stiffness and functional capacity
was maintained after correction for other variables.
The elastic properties of aorta are crucial for an optimal ventriculo-
arterial coupling [7,22] and a stiffer aorta has a negative impact on cardiac
function and functional capacity of CHF patients through different
mechanisms. First, in a stiffer aorta the cushioning effect of its proximal
tract is reduced, thus increasing LV afterload with further compromising
the ability to generate an adequate cardiac output during exercise. This
is particularly true in CHF patients because it is known that the function
of the failing heart is very dependent on the increase of afterload. Kelly
et al. have shown that a less compliant aorta may affect both LV systolic
energetics and mechanics: when the aorta was experimentally stiffened,
an increase in cardiac energetic cost for a given stroke volume (SV) was
observed [23] and SV varied inversely with aortic stiffness [24]. The
alterations of ventriculo-aortic coupling seem to further exacerbate
during exercise due to increased heart rate and an earlier reﬂection of
pulsed wave from the periphery back to the aortic root [4].
Secondly, combined ventricular–aortic stiffness could potentially
reduce the cardiovascular reserve [25]. Therefore, the ability of the
heart to accommodate the peripheral demands and the increased
pre-load during exercise may be reduced, with an increase in left atrial
pressure, and then in pulmonary capillary wedge pressure responsible
of the appearance of shortness of breath eliminating the exercise
capacity.
Thirdly, a stiffer aorta inﬂuences the exercise capacity by LV relaxa-
tion. The study of Patrianakos et al. shows a link between aortic stiffness
and amore advanced grade of diastolic dysfunction [10]. This condition is
associated with an increase of LV end-diastolic pressure at rest which
increases more during exercise for an increase in heart rate and a reduc-
tion in diastolic period.
A study on a population of patientswith CHFwith preserved ejection
fraction (HFPEF) observed that these subjects have a more stiffenedFig. 1. Correlation between aortic distensibility and pVO2 (dashed lines represent ±1
standard deviation interval).aorta and this condition could determine the development of a more
advanced diastolic dysfunction that consecutively could worsen the
ventriculo-arterial coupling and contribute to the pathophysiology of
HFPEF [26]. These data conﬁrm the positive linkage between aortic stiff-
ness and LV ﬁlling pressure. In these patients many comorbidities can
explain the less aortic distensibility and the development of HFPEF
such as elderly age [27], end-stage renal failure [28] and hypertension
[29] that are known as causes of myocardial hypertrophy, the substrate
at the basis of diastolic dysfunction.
There are several mechanisms that can affect aortic function. The
ability of the aorta to buffer the pulsatile component of the LV afterload
relies on a complex network of elastin, collagen and smoothmuscle cells
[30,31]. Changes in the relative proportion of these components alter
the elastic properties of aorta: an increase in collagen, which is more
stiffer, and a reduction of elastin, which is easily stretched, make the
arterial wall less elastic [30]. This suggests that abnormalities in extra-
cellular matrix turnover might involve the proximal elastic vasculature
and can in part explain the progressive stiffening process of large artery
in CHF [31].
The enhanced activation of renin–angiotensine–aldosterone system
(RAAS) in patients with CHF and dilated cardiomyopathy is probably an
important cause of aortic stiffness. Aortic stiffening involves vascular
smoothmuscle hypertrophy, inﬂammation, and collagen accumulation,
mechanisms which have been reported to be induced by aldosterone
[32]. Activation of RAAS leads to sodium and water accumulation in
arterial walls and determinates wall edema, thus increasing vascular
stiffness [33]. Sodium retention also promotes extracellular matrix
(ECM) synthesis and deposition and changing smooth muscle cell
phenotype, which impair vascular compliance [34]. Finally, vascular
inﬂammation, which plays an important role in the progression of CHF,
might be involved in the accelerated ECM turnover that contributes
to both myocardial and arterial ﬁbrosis [35], and a signiﬁcant relation
between high serum C-reactive protein levels and impaired aortic
compliance has been described in patients with idiopathic dilatedTable 4
Predictors of peak volume oxygen consumption (VO2).
Variable Pearson's correlation coefﬁcient p
Age −0.2640 0.0515
SAP −0.1804 0.1876
DAP −0.1777 0.1942
LVEF 0.1638 0.2322
LVMI −0.1611 0.2400
Aortic distensibility 0.47 0.0002
Aortic stiffness index −0.51 0.0001
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matoid arthritis we have previously demonstrated a correlation between
aortic stiffness and the progression of systolic and diastolic function with
a possible explanation that altered ventriculo-arterial coupling could
contribute to the pathophysiology of CHF [36].
There are potential limitations to the present study. First, we used a
noninvasive brachial cuff pressure measurement instead of a direct
assessment of the aortic pulse pressure by a catheter. It has been shown
that pulse pressure may be lower using a noninvasive method; however,
others have shown an excellent correlation (r = 0.95, p b 0.001) of the
calculated aortic distensibility using invasive and noninvasive methods
[37]. Second, most of our patients with systolic CHF received long-term
medication with agents that might improve aortic distensibility (such as
spironolactone) or decrease exercise tolerance (such as beta-blockers).
Third, it is possible that impaired systolic performance could directly
affect aortic distensibility in patients with systolic CHF; however, it is
known that stroke volume and cardiac output are usually adequate in
compensated patients with systolic CHF at rest. Moreover in our popula-
tion no association was found between aortic stiffness and LVEF. Fourth,
since 96% of our population was treated with beta-blockers we can
hypothesize that these drugs may have inﬂuenced aortic elastic proper-
ties. To our knowledge, no studies have already evaluated the effects of
beta-blockers on ascending aorta distensibility and stiffness.
In conclusion this study conﬁrms that among HF patients with NIDC
aortic stiffness is correlated with peak VO2 and is an independent
predictor of exercise capacity. These data suggest that decreased aortic
distensibility may cause hemodynamic impairment. Aortic stiffness
has a negative impact on cardiac function and functional capacity.
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